APA

Borgan F., Laurikainen H., Veronese M., Marques T. R., Haaparanta-Solin M., Solin O., Dahoun T., Rogdaki M., Salokangas R. K., Karukivi M., Di Forti M., Turkheimer F., Hietala J. & Howes O. (20210121). In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis. : JAMA psychiatry.

Chicago

Borgan Faith, Laurikainen Heikki, Veronese Mattia, Marques Tiago Reis, Haaparanta-Solin Merja, Solin Olof, Dahoun Tarik, Rogdaki Maria, Salokangas Raimo Kr, Karukivi Max, Di Forti Marta, Turkheimer Federico, Hietala Jarmo and Howes Oliver. 20210121. In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis. : JAMA psychiatry.

Harvard

Borgan F., Laurikainen H., Veronese M., Marques T. R., Haaparanta-Solin M., Solin O., Dahoun T., Rogdaki M., Salokangas R. K., Karukivi M., Di Forti M., Turkheimer F., Hietala J. and Howes O. (20210121). In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis. : JAMA psychiatry.

MLA

Borgan Faith, Laurikainen Heikki, Veronese Mattia, Marques Tiago Reis, Haaparanta-Solin Merja, Solin Olof, Dahoun Tarik, Rogdaki Maria, Salokangas Raimo Kr, Karukivi Max, Di Forti Marta, Turkheimer Federico, Hietala Jarmo and Howes Oliver. In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis. : JAMA psychiatry. 20210121.